Search research articles
Contact Us
Filters
Showing results (1-10 of 92) with videos related to
Page
of 10
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 3, 2020
Imaging inflammation in atherosclerosis: Exploring all avenues
Achi Haider, Susan Bengs, Catherine Gebhard
Trends in Pharmacological Sciences
|
August 14, 2025
<sup>18</sup>F-Flurpiridaz PET for imaging of myocardial ischemia
Taoqian Zhao, Achi Haider, Steven H Liang
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
November 4, 2020
Hybrid positron emission tomography and magnetic resonance imaging in carotid atherosclerosis: Not ready for prime time?
Achi Haider, Susan Bengs, Catherine Gebhard, et al.
Frontiers in Neuroscience
|
December 28, 2020
The Neuro-Inflammatory-Vascular Circuit: Evidence for a Sex-Dependent Interrelation?
Catherine Gebhard, Susan Bengs, Achi Haider, et al.
Nature Communications
|
June 5, 2023
Radiochemistry for positron emission tomography
Jian Rong, Achi Haider, Troels E Jeppesen, et al.
Chemmedchem
|
March 10, 2018
Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies
Marina Szermerski, Frederik Börgel, Dirk Schepmann, et al.
Nature Reviews. Endocrinology
|
December 9, 2022
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E Gebhard, Susan Bengs, et al.
Frontiers in Aging Neuroscience
|
October 17, 2022
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease
Vasil Kecheliev, Francesco Spinelli, Adrienne Herde, et al.
Journal of Neurochemistry
|
July 8, 2016
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Roger Slavik, Adrienne Müller Herde, Achi Haider, et al.
Molecular Neurodegeneration
|
February 10, 2023
Translational molecular imaging and drug development in Parkinson's disease
Achi Haider, Nehal H Elghazawy, Alyaa Dawoud, et al.
Page
of 10
Search research articles
Search
Showing results (1-10 of 92) with videos related to
Sort By:
Page
of 10
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
April 3, 2020
Imaging inflammation in atherosclerosis: Exploring all avenues
Achi Haider, Susan Bengs, Catherine Gebhard
Trends in Pharmacological Sciences
|
August 14, 2025
<sup>18</sup>F-Flurpiridaz PET for imaging of myocardial ischemia
Taoqian Zhao, Achi Haider, Steven H Liang
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology
|
November 4, 2020
Hybrid positron emission tomography and magnetic resonance imaging in carotid atherosclerosis: Not ready for prime time?
Achi Haider, Susan Bengs, Catherine Gebhard, et al.
Frontiers in Neuroscience
|
December 28, 2020
The Neuro-Inflammatory-Vascular Circuit: Evidence for a Sex-Dependent Interrelation?
Catherine Gebhard, Susan Bengs, Achi Haider, et al.
Nature Communications
|
June 5, 2023
Radiochemistry for positron emission tomography
Jian Rong, Achi Haider, Troels E Jeppesen, et al.
Chemmedchem
|
March 10, 2018
Fluorinated GluN2B Receptor Antagonists with a 3-Benzazepine Scaffold Designed for PET Studies
Marina Szermerski, Frederik Börgel, Dirk Schepmann, et al.
Nature Reviews. Endocrinology
|
December 9, 2022
Sex hormones in SARS-CoV-2 susceptibility: key players or confounders?
Nicola Lott, Caroline E Gebhard, Susan Bengs, et al.
Frontiers in Aging Neuroscience
|
October 17, 2022
Evaluation of cannabinoid type 2 receptor expression and pyridine-based radiotracers in brains from a mouse model of Alzheimer's disease
Vasil Kecheliev, Francesco Spinelli, Adrienne Herde, et al.
Journal of Neurochemistry
|
July 8, 2016
Discovery of a fluorinated 4-oxo-quinoline derivative as a potential positron emission tomography radiotracer for imaging cannabinoid receptor type 2
Roger Slavik, Adrienne Müller Herde, Achi Haider, et al.
Molecular Neurodegeneration
|
February 10, 2023
Translational molecular imaging and drug development in Parkinson's disease
Achi Haider, Nehal H Elghazawy, Alyaa Dawoud, et al.
Page
of 10